ATLANTA — A drug that has been shown to shorten the recovery time for some COVID-19 patients is now available at three hospitals operated by Piedmont Healthcare.

Piedmont is participating in the U.S. Food and Drug Administration’s (FDA) expanded access program for the antiviral drug remdesivir, which was granted emergency use authorization May 1.

The drug is available to patients at Piedmont Atlanta Hospital, Piedmont Fayette Hospital and at Piedmont Columbus Regional’s Midtown campus and may be expanded to other Piedmont hospitals.

FDA expanded access programs allow patients with immediately life-threatening conditions or a serious disease access to an investigational medical product outside of clinical trials when no comparable or alternative options are available.

“Piedmont’s providers have been on the front lines of the COVID-19 pandemic,” said Dr. Charles Brown, CEO of Piedmont Healthcare’s Physician Enterprise. “Remdesivir gives them another tool to help care for our patients.”

For Piedmont, this will represent the second chance to work with remdesivir.

“We had a positive experience with remdesivir early in the pandemic and are excited to be able to provide to our patients again,” said Dr. Amy Hajari Case, Piedmont’s medical director of pulmonary and critical care research and principal site director for the program at Piedmont Atlanta.

Support Local Journalism

Now, more than ever, residents need trustworthy reporting—but good journalism isn’t free. Please support us by purchasing a digital subscription. Your subscription will allow you unlimited access to important local news stories. Our mission is to keep our community informed and we appreciate your support.


Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.